Phage Therapy Kits refer to the use of bacteriophages, which are viruses that target and destroy specific bacterial strains, for the treatment of bacterial infections. These kits typically contain a selection of phages that can be used to treat infections that are resistant to antibiotics.
The global Phage Therapy Kits market was valued at US$ 35.6 million in 2023 and is anticipated to reach US$ 100 million by 2030, witnessing a CAGR of 15.6% during the forecast period 2024-2030.
Phage therapy, the therapeutic use of bacteriophages (viruses that infect bacteria), is a promising field with significant potential to address the growing challenge of antibiotic resistance. As such, the market for phage therapy kits is expected to experience substantial growth in the coming years.
Here are some key trends that are likely to shape the future market for phage therapy kits:
1. Increasing Prevalence of Antibiotic Resistance:
Rising antibiotic resistance: The overuse and misuse of antibiotics have led to a global increase in antibiotic-resistant bacteria, making traditional treatments less effective. This will drive demand for alternative solutions like phage therapy.
Expanded applications: Phage therapy is being explored for a wide range of infections, including skin infections, urinary tract infections, and respiratory infections. As research progresses and clinical trials demonstrate efficacy, the market for phage therapy kits will expand.
2. Advancements in Phage Research and Development:
Improved phage identification and characterization: Technological advancements will enable faster and more accurate identification and characterization of phages, leading to the development of more targeted and effective phage therapy kits.
Enhanced phage engineering: Researchers are exploring ways to engineer phages to improve their therapeutic properties, such as increasing their stability, broadening their host range, and enhancing their ability to overcome bacterial defenses.
3. Growing Regulatory Acceptance:
Regulatory approvals: As regulatory bodies gain more experience with phage therapy, we can expect to see an increase in approvals for phage therapy products. This will provide greater market access and boost investor confidence.
International collaboration: Global cooperation and harmonization of regulatory frameworks will facilitate the development and commercialization of phage therapy kits across different regions.
4. Increased Investment and Industry Interest:
Venture capital and pharmaceutical investments: The potential of phage therapy to address the antibiotic resistance crisis has attracted significant investment from venture capital firms and pharmaceutical companies. This increased interest will drive innovation and accelerate the development of phage therapy kits.
Partnerships and collaborations: Strategic partnerships between academic institutions, research organizations, and biotechnology companies will foster collaboration and accelerate the translation of phage therapy research into commercial products.
5. Personalized Phage Therapy:
Tailored phage cocktails: Advancements in genomics and personalized medicine will enable the development of customized phage cocktails that are specifically tailored to individual patients and their unique infections.
Precision phage therapy: This approach will improve treatment outcomes and reduce the risk of adverse effects.
Overall, the future market for phage therapy kits is poised for significant growth driven by the increasing prevalence of antibiotic resistance, advancements in phage research, regulatory acceptance, increased investment, and the potential for personalized phage therapy. As the field continues to evolve, we can expect to see a wider range of phage therapy products becoming available to patients, offering new hope for the treatment of antibiotic-resistant infections.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Phage Therapy Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phage Therapy Kits.
The Phage Therapy Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Phage Therapy Kits market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phage Therapy Kits manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BiomX
PhagePro
PhagoMed Biopharma
MYRIADE
DotBio
Wuhan Greinon Biotechnology
PhagePharm
iNtRON Biotechnology
Snipr Technologies
CJ
Phico Therapeutics
Segment by Type
Medical Grade
Laboratory Grade
Segment by Application
Medical
Food Industry
Agriculture
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Phage Therapy Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Phage Therapy Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Phage Therapy Kits Market Overview
1.1 Product Definition
1.2 Phage Therapy Kits by Type
1.2.1 Global Phage Therapy Kits Market Value Comparison by Type (2024-2030)
1.2.2 Medical Grade
1.2.3 Laboratory Grade
1.3 Phage Therapy Kits by Application
1.3.1 Global Phage Therapy Kits Market Value by Application (2024-2030)
1.3.2 Medical
1.3.3 Food Industry
1.3.4 Agriculture
1.3.5 Others
1.4 Global Phage Therapy Kits Market Size Estimates and Forecasts
1.4.1 Global Phage Therapy Kits Revenue 2019-2030
1.4.2 Global Phage Therapy Kits Sales 2019-2030
1.4.3 Global Phage Therapy Kits Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Phage Therapy Kits Market Competition by Manufacturers
2.1 Global Phage Therapy Kits Sales Market Share by Manufacturers (2019-2024)
2.2 Global Phage Therapy Kits Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Phage Therapy Kits Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Phage Therapy Kits, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Phage Therapy Kits, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Phage Therapy Kits, Product Type & Application
2.7 Global Key Manufacturers of Phage Therapy Kits, Date of Enter into This Industry
2.8 Global Phage Therapy Kits Market Competitive Situation and Trends
2.8.1 Global Phage Therapy Kits Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Phage Therapy Kits Players Market Share by Revenue
2.8.3 Global Phage Therapy Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Phage Therapy Kits Market Scenario by Region
3.1 Global Phage Therapy Kits Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Phage Therapy Kits Sales by Region: 2019-2030
3.2.1 Global Phage Therapy Kits Sales by Region: 2019-2024
3.2.2 Global Phage Therapy Kits Sales by Region: 2025-2030
3.3 Global Phage Therapy Kits Revenue by Region: 2019-2030
3.3.1 Global Phage Therapy Kits Revenue by Region: 2019-2024
3.3.2 Global Phage Therapy Kits Revenue by Region: 2025-2030
3.4 North America Phage Therapy Kits Market Facts & Figures by Country
3.4.1 North America Phage Therapy Kits Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Phage Therapy Kits Sales by Country (2019-2030)
3.4.3 North America Phage Therapy Kits Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Phage Therapy Kits Market Facts & Figures by Country
3.5.1 Europe Phage Therapy Kits Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Phage Therapy Kits Sales by Country (2019-2030)
3.5.3 Europe Phage Therapy Kits Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Phage Therapy Kits Market Facts & Figures by Region
3.6.1 Asia Pacific Phage Therapy Kits Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Phage Therapy Kits Sales by Region (2019-2030)
3.6.3 Asia Pacific Phage Therapy Kits Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Phage Therapy Kits Market Facts & Figures by Country
3.7.1 Latin America Phage Therapy Kits Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Phage Therapy Kits Sales by Country (2019-2030)
3.7.3 Latin America Phage Therapy Kits Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Phage Therapy Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa Phage Therapy Kits Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Phage Therapy Kits Sales by Country (2019-2030)
3.8.3 Middle East and Africa Phage Therapy Kits Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Phage Therapy Kits Sales by Type (2019-2030)
4.1.1 Global Phage Therapy Kits Sales by Type (2019-2024)
4.1.2 Global Phage Therapy Kits Sales by Type (2025-2030)
4.1.3 Global Phage Therapy Kits Sales Market Share by Type (2019-2030)
4.2 Global Phage Therapy Kits Revenue by Type (2019-2030)
4.2.1 Global Phage Therapy Kits Revenue by Type (2019-2024)
4.2.2 Global Phage Therapy Kits Revenue by Type (2025-2030)
4.2.3 Global Phage Therapy Kits Revenue Market Share by Type (2019-2030)
4.3 Global Phage Therapy Kits Price by Type (2019-2030)
5 Segment by Application
5.1 Global Phage Therapy Kits Sales by Application (2019-2030)
5.1.1 Global Phage Therapy Kits Sales by Application (2019-2024)
5.1.2 Global Phage Therapy Kits Sales by Application (2025-2030)
5.1.3 Global Phage Therapy Kits Sales Market Share by Application (2019-2030)
5.2 Global Phage Therapy Kits Revenue by Application (2019-2030)
5.2.1 Global Phage Therapy Kits Revenue by Application (2019-2024)
5.2.2 Global Phage Therapy Kits Revenue by Application (2025-2030)
5.2.3 Global Phage Therapy Kits Revenue Market Share by Application (2019-2030)
5.3 Global Phage Therapy Kits Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BiomX
6.1.1 BiomX Company Information
6.1.2 BiomX Description and Business Overview
6.1.3 BiomX Phage Therapy Kits Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BiomX Phage Therapy Kits Product Portfolio
6.1.5 BiomX Recent Developments/Updates
6.2 PhagePro
6.2.1 PhagePro Company Information
6.2.2 PhagePro Description and Business Overview
6.2.3 PhagePro Phage Therapy Kits Sales, Revenue and Gross Margin (2019-2024)
6.2.4 PhagePro Phage Therapy Kits Product Portfolio
6.2.5 PhagePro Recent Developments/Updates
6.3 PhagoMed Biopharma
6.3.1 PhagoMed Biopharma Company Information
6.3.2 PhagoMed Biopharma Description and Business Overview
6.3.3 PhagoMed Biopharma Phage Therapy Kits Sales, Revenue and Gross Margin (2019-2024)
6.3.4 PhagoMed Biopharma Phage Therapy Kits Product Portfolio
6.3.5 PhagoMed Biopharma Recent Developments/Updates
6.4 MYRIADE
6.4.1 MYRIADE Company Information
6.4.2 MYRIADE Description and Business Overview
6.4.3 MYRIADE Phage Therapy Kits Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MYRIADE Phage Therapy Kits Product Portfolio
6.4.5 MYRIADE Recent Developments/Updates
6.5 DotBio
6.5.1 DotBio Company Information
6.5.2 DotBio Description and Business Overview
6.5.3 DotBio Phage Therapy Kits Sales, Revenue and Gross Margin (2019-2024)
6.5.4 DotBio Phage Therapy Kits Product Portfolio
6.5.5 DotBio Recent Developments/Updates
6.6 Wuhan Greinon Biotechnology
6.6.1 Wuhan Greinon Biotechnology Company Information
6.6.2 Wuhan Greinon Biotechnology Description and Business Overview
6.6.3 Wuhan Greinon Biotechnology Phage Therapy Kits Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Wuhan Greinon Biotechnology Phage Therapy Kits Product Portfolio
6.6.5 Wuhan Greinon Biotechnology Recent Developments/Updates
6.7 PhagePharm
6.7.1 PhagePharm Company Information
6.7.2 PhagePharm Description and Business Overview
6.7.3 PhagePharm Phage Therapy Kits Sales, Revenue and Gross Margin (2019-2024)
6.7.4 PhagePharm Phage Therapy Kits Product Portfolio
6.7.5 PhagePharm Recent Developments/Updates
6.8 iNtRON Biotechnology
6.8.1 iNtRON Biotechnology Company Information
6.8.2 iNtRON Biotechnology Description and Business Overview
6.8.3 iNtRON Biotechnology Phage Therapy Kits Sales, Revenue and Gross Margin (2019-2024)
6.8.4 iNtRON Biotechnology Phage Therapy Kits Product Portfolio
6.8.5 iNtRON Biotechnology Recent Developments/Updates
6.9 Snipr Technologies
6.9.1 Snipr Technologies Company Information
6.9.2 Snipr Technologies Description and Business Overview
6.9.3 Snipr Technologies Phage Therapy Kits Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Snipr Technologies Phage Therapy Kits Product Portfolio
6.9.5 Snipr Technologies Recent Developments/Updates
6.10 CJ
6.10.1 CJ Company Information
6.10.2 CJ Description and Business Overview
6.10.3 CJ Phage Therapy Kits Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CJ Phage Therapy Kits Product Portfolio
6.10.5 CJ Recent Developments/Updates
6.11 Phico Therapeutics
6.11.1 Phico Therapeutics Company Information
6.11.2 Phico Therapeutics Description and Business Overview
6.11.3 Phico Therapeutics Phage Therapy Kits Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Phico Therapeutics Phage Therapy Kits Product Portfolio
6.11.5 Phico Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Phage Therapy Kits Industry Chain Analysis
7.2 Phage Therapy Kits Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Phage Therapy Kits Production Mode & Process
7.4 Phage Therapy Kits Sales and Marketing
7.4.1 Phage Therapy Kits Sales Channels
7.4.2 Phage Therapy Kits Distributors
7.5 Phage Therapy Kits Customers
8 Phage Therapy Kits Market Dynamics
8.1 Phage Therapy Kits Industry Trends
8.2 Phage Therapy Kits Market Drivers
8.3 Phage Therapy Kits Market Challenges
8.4 Phage Therapy Kits Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
BiomX
PhagePro
PhagoMed Biopharma
MYRIADE
DotBio
Wuhan Greinon Biotechnology
PhagePharm
iNtRON Biotechnology
Snipr Technologies
CJ
Phico Therapeutics
听
听
*If Applicable.
